Sign In

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.


Abcam and Transinsight agree on collaboration in the area of semantic search technologies

Abcam and Transinsight agree on collaboration in the area of semantic search technologies for finding antibodies

Cambridge, UK / Dresden, Germany - 13th August 2008

Abcam, a bioscience company specialising in the supply of antibodies from a web-based catalogue and Transinsight, a specialist in semantic search technologies are pleased to announce a collaboration in the field of protein information quality control using bioinformatics workflows.

Accurately compiling all the required information around antibody targets is a challenging task, which has created the requirement for an automated intelligent computer-based solution to ensure top-quality information content about proteins. For example, an average human gene name has 6 or 7 synonyms and many more spelling variants. Hand-curated databases do not cover all possible ways of naming and spelling genes and hand-curation is a tedious, error prone and labour-intensive task.

'Until recently there were only limited software tools and scientific workflows available to help us automatically produce high quality data sets surrounding each of Abcam's thousands of antibody targets. We need these data sets to help our customers find the right products', says Dr. Harter, Senior Business Development Manager at Abcam. Harter continues 'We were looking for solutions for supporting our team of experts and were impressed by the advanced technologies of Transinsight. The fact that the company operates the semantic search engine and has extensive bioinformatics and protein databases expertise made the decision to work with Transinsight easy.'

The award winning technology behind GoPubMed fully automates very difficult analyses normally done by scientists with equal or better performance, predicting the necessary information by sophisticated algorithms. 'It is good to see how we can significantly enhance our customers' performance by improving their data quality and thus freeing their staff from an unnecessary burden' says Michael R. Alvers, CEO at Transinsight.

*About Abcam*
Abcam plc is a producer and distributor of research-grade antibodies and associated products headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office located in Tokyo. The Company produces and distributes its own and third party produced antibodies to academic and commercial customers throughout the world with product information and ordering available through the Company's website, Abcam's vision is to build the largest online catalogue of the best antibodies in the world.

*About Transinsight*
Transinsight develops knowledge-based semantic solutions in the Life Sciences. Their flagship products and, renowned biomedical search engines, are the first knowledge-based search systems of the next generation for the Life Sciences on the internet. In acknowledgement of the technologies developed by the company, Transinsight has repeatedly been honoured with international awards. The firm works in close collaboration with the Dresden University of Technology. Selected customers are: Unilever, BASF, BfR, StatoilHydro, Wintershall, Abcam and EMBL. For further information on Transinsight on the internet, see

Transinsight GmbH
Tatzberg 47-51
D-01307 Dresden, Germany

Tel: +49 351 796 57 80

CEO/Geschäftsführer Dr. Michael R. Alvers
HRB 24231, Amtsgericht Dresden

Publisher Contact Information:

Transinsight GmbH
+49 351 796 57 80

Company profile of Transinsight GmbH
Past press releases of Transinsight GmbH.


Tech investments
From our Online Data Service
VC-backed companies
From our Radar

Recent Deals

Aug 12€2.4MBusiness applications
Aug 12€0.7MMedical devices
Aug 12N/AMedical devices
Aug 9€7.0MSoftware development
Aug 9€0.3MeLearning
Aug 9N/AOther Biotechnology & Healthcare
Aug 7€3.8MDiagnostics

For information on Europe's most extensive database on technology funding click here!


Press Releases

May 28
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises £1m in seed funding to build tech-enabled home ...

About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.